The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
In the latest session, Stericycle Inc. (NASDAQ: SRCL) closed at $45.42 down -1.92% from its previous closing price of $46.31. In other words, the price has decreased by -$1.92 from its previous closing price. On the day, 0.77 million shares were traded. SRCL stock price reached its highest trading level at $46.74 during the session, while it also had its lowest trading level at $45.311.
Ratios:
For a deeper understanding of Stericycle Inc.’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 135.63 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 3234.25. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.09. In the meantime, Its Debt-to-Equity ratio is 0.77 whereas as Long-Term Debt/Eq ratio is at 0.72.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on December 08, 2023, initiated with a Underweight rating and assigned the stock a target price of $40.
On April 18, 2023, Truist started tracking the stock assigning a Hold rating and target price of $45.
Robert W. Baird Downgraded its Outperform to Neutral on February 24, 2023, whereas the target price for the stock was revised from $65 to $53.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 07 ’23 when Reuter Joseph Anthony bought 7,000 shares for $44.09 per share. The transaction valued at 308,619 led to the insider holds 24,209 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SRCL now has a Market Capitalization of 4296590848 and an Enterprise Value of 6116509184. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.59 while its Price-to-Book (P/B) ratio in mrq is 1.67. Its current Enterprise Value per Revenue stands at 2.317 whereas that against EBITDA is 15.025.
Stock Price History:
The Beta on a monthly basis for SRCL is 1.10, which has changed by 0.02505076 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, SRCL has reached a high of $57.06, while it has fallen to a 52-week low of $37.78. The 50-Day Moving Average of the stock is -11.48%, while the 200-Day Moving Average is calculated to be -3.25%.
Shares Statistics:
For the past three months, SRCL has traded an average of 482.43K shares per day and 608440 over the past ten days. A total of 92.20M shares are outstanding, with a floating share count of 92.12M. Insiders hold about 0.49% of the company’s shares, while institutions hold 106.57% stake in the company. Shares short for SRCL as of 1713139200 were 1881389 with a Short Ratio of 3.90, compared to 1710460800 on 2099037. Therefore, it implies a Short% of Shares Outstanding of 1881389 and a Short% of Float of 2.0399998999999998.
Earnings Estimates
Current recommendations for the stock of the company come from 6.0 analysts. On average, analysts expect EPS of $0.57 for the current quarter, with a high estimate of $0.58 and a low estimate of $0.55, while EPS last year was $0.43. The consensus estimate for the next quarter is $0.58, with high estimates of $0.59 and low estimates of $0.56.
Analysts are recommending an EPS of between $2.38 and $2.27 for the fiscal current year, implying an average EPS of $2.31. EPS for the following year is $2.8, with 7.0 analysts recommending between $3.0 and $2.66.
Revenue Estimates
A total of 6 analysts believe the company’s revenue will be $671.85M this quarter.It ranges from a high estimate of $677.9M to a low estimate of $666.6M. As of the current estimate, Stericycle Inc.’s year-ago sales were $669.5MFor the next quarter, 6 analysts are estimating revenue of $677.23M. There is a high estimate of $683.1M for the next quarter, whereas the lowest estimate is $667.4M.
A total of 7 analysts have provided revenue estimates for SRCL’s current fiscal year. The highest revenue estimate was $2.72B, while the lowest revenue estimate was $2.68B, resulting in an average revenue estimate of $2.7B. In the same quarter a year ago, actual revenue was $2.66BBased on 7 analysts’ estimates, the company’s revenue will be $2.8B in the next fiscal year. The high estimate is $2.83B and the low estimate is $2.77B.
